Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
EDEN-PSE: Edaravone Dexborneol for Prevention of Post-Stroke Epilepsy
NCT07604350Phase 3Not yet recruiting
- Sponsor
- The First Affiliated Hospital of Wenzhou Medical University
- Start
- Jun 2026
- Primary completion
- Jun 2030
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of edaravone dexborneol in epilepsy, sponsored by The First Affiliated Hospital of Wenzhou Medical University. Planned start Jun 2026; status: not yet recruiting.
02
Drugs
edaravone dexborneol
03
Conditions
epilepsy
Beyond the preview
Go deeper on NCT07604350.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07604350.